InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Explore the detailed record of transactions filed by KROLL MARK W, Director. Director active across 3 companies, notably Axon Enterprise, INC.. Aggregated, 10 filings have been published. Total volume traded: €1.2m. The latest transaction was disclosed on 8 June 2022 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations10 total
€303,0473,159 shares@ €95.93140.0010% mcap17.9% of flow
Common Stock
SEC:0001415889-22-006379:0·
€189,1412,013 shares@ €93.95980.0006% mcap11.2% of flow
Common Stock
SEC:0001415889-22-005551:0·
3,077 shares
Common Stock
SEC:0001127602-21-023396·
3,077 shares
Common Stock
SEC:0001127602-21-023396:0·
€164,0381,434 shares@ €114.39170.0005% mcap27.4% of flow
Common Stock
SEC:0001415889-21-002731·
€164,0381,434 shares@ €114.39170.0005% mcap9.7% of flow
Common Stock
SEC:0001415889-21-002731:0·
€301,46010,353 shares@ €29.11810.0098% mcap100.0% of flow
Common Stock
SEC:0001127602-21-018310·
€301,46010,353 shares@ €29.11810.012% mcap100.0% of flow
Common Stock
SEC:0001127602-21-018310:0·
€434,8724,204 shares@ €103.44240.0014% mcap72.6% of flow
Common Stock
SEC:0001415889-21-002470·
€434,8724,204 shares@ €103.44240.0014% mcap25.7% of flow
Common Stock
SEC:0001415889-21-002470:0·
10 of 10 declarations
About KROLL MARK W
Mark W. Kroll is a Board Member at AXON ENTERPRISE, INC. and HAEMONETICS CORP. He brings extensive experience in corporate governance and strategy, contributing to the leadership and decision-making within the boards of these companies.
